Tevogen Bio Holdings IncNASDAQ:TVGN
- LAST PRICE1.0000
- TODAY'S CHANGE (%)0.1500 (17.6471%)
- Bid / Lots0.9400/ 6
- Ask / Lots1.0000/ 245
- Open / Previous Close1.2000 / 0.8500
- Day Range
- 52 Week Range
- Volume10,793,108
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TVGN |
|---|---|---|
| 09:32 ET | 238661 | 1.13 |
| 09:34 ET | 236636 | 1.125 |
| 09:36 ET | 222589 | 1.09 |
| 09:38 ET | 228523 | 1.08 |
| 09:39 ET | 53267 | 1.0899 |
| 09:41 ET | 156986 | 1.0784 |
| 09:43 ET | 47206 | 1.1 |
| 09:45 ET | 112778 | 1.03 |
| 09:48 ET | 337609 | 1.03 |
| 09:50 ET | 41139 | 1.04 |
| 09:52 ET | 30630 | 1.0407 |
| 09:54 ET | 30056 | 1.0398 |
| 09:56 ET | 27602 | 1.02 |
| 09:57 ET | 28789 | 1.01 |
| 09:59 ET | 17112 | 1.0199 |
| 10:01 ET | 22352 | 1.015 |
| 10:03 ET | 14814 | 1.01 |
| 10:06 ET | 10382 | 1.02 |
| 10:08 ET | 10454 | 1.02 |
| 10:10 ET | 51078 | 0.978 |
| 10:12 ET | 118923 | 0.9609 |
| 10:14 ET | 90052 | 0.9498 |
| 10:15 ET | 58883 | 0.97 |
| 10:17 ET | 35067 | 0.9568 |
| 10:19 ET | 17231 | 0.974899 |
| 10:21 ET | 17045 | 0.9655 |
| 10:24 ET | 20897 | 0.985 |
| 10:26 ET | 13313 | 0.9841 |
| 10:28 ET | 31063 | 0.9737 |
| 10:30 ET | 43633 | 0.9691 |
| 10:32 ET | 12085 | 0.965 |
| 10:33 ET | 32150 | 0.9748 |
| 10:35 ET | 29740 | 0.9895 |
| 10:37 ET | 39799 | 1.01 |
| 10:39 ET | 47574 | 1.0199 |
| 10:42 ET | 13462 | 1.015 |
| 10:44 ET | 33335 | 1.0189 |
| 10:46 ET | 19661 | 1.01 |
| 10:48 ET | 7420 | 1.01 |
| 10:50 ET | 5162 | 1 |
| 10:51 ET | 3950 | 0.9901 |
| 10:53 ET | 14030 | 0.966 |
| 10:55 ET | 54959 | 0.9921 |
| 10:57 ET | 9859 | 0.969999 |
| 11:00 ET | 3270 | 0.970101 |
| 11:02 ET | 12617 | 0.95 |
| 11:04 ET | 1779 | 0.96 |
| 11:06 ET | 10055 | 0.97 |
| 11:08 ET | 5905 | 0.9819 |
| 11:09 ET | 12935 | 0.991 |
| 11:11 ET | 14940 | 1 |
| 11:13 ET | 7462 | 1 |
| 11:15 ET | 27253 | 1.005 |
| 11:18 ET | 1769 | 1.01 |
| 11:20 ET | 4244 | 1.005 |
| 11:22 ET | 14582 | 0.9968 |
| 11:24 ET | 4815 | 0.9914 |
| 11:26 ET | 17512 | 0.9724 |
| 11:27 ET | 15597 | 0.9641 |
| 11:29 ET | 3100 | 0.9973 |
| 11:31 ET | 2313 | 0.9985 |
| 11:33 ET | 16240 | 0.9984 |
| 11:36 ET | 2466 | 0.9774 |
| 11:38 ET | 2392 | 0.9773 |
| 11:40 ET | 28289 | 0.9951 |
| 11:42 ET | 4378 | 0.995 |
| 11:44 ET | 100 | 0.9919 |
| 11:45 ET | 2865 | 0.9949 |
| 11:47 ET | 12862 | 0.9924 |
| 11:51 ET | 14561 | 0.9801 |
| 11:54 ET | 7031 | 0.99 |
| 11:56 ET | 5852 | 1.01 |
| 11:58 ET | 653 | 1.01 |
| 12:00 ET | 100406 | 1.02 |
| 12:02 ET | 60762 | 1.0507 |
| 12:03 ET | 54262 | 1.085 |
| 12:05 ET | 45807 | 1.04 |
| 12:07 ET | 29268 | 1.05 |
| 12:09 ET | 3864 | 1.055 |
| 12:12 ET | 16413 | 1.05 |
| 12:14 ET | 3256 | 1.042 |
| 12:16 ET | 22940 | 1.0379 |
| 12:18 ET | 3892 | 1.04 |
| 12:20 ET | 4785 | 1.035 |
| 12:21 ET | 14819 | 1.05 |
| 12:23 ET | 5118 | 1.05 |
| 12:25 ET | 2380 | 1.04 |
| 12:27 ET | 32273 | 0.9901 |
| 12:30 ET | 21075 | 0.9995 |
| 12:32 ET | 10406 | 1.04 |
| 12:34 ET | 9229 | 1.03 |
| 12:36 ET | 1947 | 1.0315 |
| 12:39 ET | 1042 | 1.0114 |
| 12:41 ET | 3215 | 1.01 |
| 12:43 ET | 6848 | 1.03 |
| 12:45 ET | 704 | 1 |
| 12:48 ET | 2837 | 1.02 |
| 12:50 ET | 200 | 1.02 |
| 12:52 ET | 1777 | 1.03 |
| 12:59 ET | 1970 | 1.0108 |
| 01:01 ET | 3259 | 1.02 |
| 01:06 ET | 390 | 1.0197 |
| 01:08 ET | 2531 | 1.02 |
| 01:10 ET | 5752 | 1 |
| 01:12 ET | 8122 | 1.0011 |
| 01:14 ET | 1000 | 1.01 |
| 01:15 ET | 3322 | 1.005 |
| 01:17 ET | 1103 | 1.01 |
| 01:19 ET | 2100 | 1.01 |
| 01:21 ET | 1213 | 1.0007 |
| 01:24 ET | 1400 | 1.01 |
| 01:26 ET | 440 | 1.001 |
| 01:28 ET | 5440 | 1.005 |
| 01:32 ET | 877 | 1 |
| 01:33 ET | 1700 | 1.005 |
| 01:35 ET | 581 | 1 |
| 01:37 ET | 1600 | 1.005 |
| 01:39 ET | 4837 | 1.003 |
| 01:42 ET | 1359 | 1.01 |
| 01:44 ET | 2781 | 1.005 |
| 01:46 ET | 1050 | 1 |
| 01:48 ET | 6129 | 1 |
| 01:50 ET | 2529 | 0.988 |
| 01:51 ET | 3560 | 0.9996 |
| 01:53 ET | 2655 | 1 |
| 01:55 ET | 1200 | 1.005 |
| 01:57 ET | 7477 | 1 |
| 02:00 ET | 200 | 1 |
| 02:02 ET | 2500 | 1 |
| 02:04 ET | 1455 | 0.99 |
| 02:06 ET | 300 | 1 |
| 02:08 ET | 700 | 1 |
| 02:09 ET | 400 | 0.9975 |
| 02:11 ET | 7677 | 1 |
| 02:13 ET | 700 | 0.995 |
| 02:15 ET | 1000 | 0.9955 |
| 02:18 ET | 398 | 0.9955 |
| 02:20 ET | 1098 | 0.9955 |
| 02:22 ET | 2907 | 0.9833 |
| 02:24 ET | 45448 | 0.941 |
| 02:26 ET | 6210 | 0.955 |
| 02:27 ET | 2532 | 0.9521 |
| 02:29 ET | 11513 | 0.9401 |
| 02:31 ET | 4154 | 0.9959 |
| 02:36 ET | 100 | 0.9749 |
| 02:38 ET | 1500 | 0.995 |
| 02:40 ET | 650 | 0.96 |
| 02:42 ET | 3780 | 0.9486 |
| 02:44 ET | 3487 | 0.96 |
| 02:45 ET | 8700 | 0.9749 |
| 02:47 ET | 12681 | 0.9945 |
| 02:49 ET | 2034 | 0.9945 |
| 02:51 ET | 6386 | 0.98335 |
| 02:54 ET | 16055 | 0.9944 |
| 02:56 ET | 5074 | 0.9516 |
| 02:58 ET | 5557 | 0.9516 |
| 03:00 ET | 1386 | 0.99 |
| 03:02 ET | 100 | 0.99 |
| 03:03 ET | 2089 | 0.99 |
| 03:05 ET | 2800 | 0.987 |
| 03:07 ET | 3800 | 0.98 |
| 03:09 ET | 900 | 0.98 |
| 03:12 ET | 581 | 0.9877 |
| 03:14 ET | 8557 | 0.9898 |
| 03:16 ET | 1600 | 0.955 |
| 03:18 ET | 3318 | 0.96 |
| 03:20 ET | 7526 | 0.97 |
| 03:21 ET | 13901 | 0.9601 |
| 03:23 ET | 900 | 0.97 |
| 03:25 ET | 400 | 0.9899 |
| 03:27 ET | 10993 | 0.9899 |
| 03:30 ET | 2615 | 0.9899 |
| 03:32 ET | 19469 | 1.005 |
| 03:34 ET | 1525 | 1.01 |
| 03:36 ET | 5870 | 1.02 |
| 03:38 ET | 15988 | 1.01 |
| 03:39 ET | 1933 | 1 |
| 03:41 ET | 8044 | 1 |
| 03:43 ET | 30892 | 1.01 |
| 03:45 ET | 26612 | 1.005 |
| 03:48 ET | 13645 | 0.975 |
| 03:50 ET | 7925 | 0.975 |
| 03:52 ET | 11780 | 0.975 |
| 03:54 ET | 38554 | 0.9648 |
| 03:56 ET | 19361 | 0.965 |
| 03:57 ET | 9632 | 0.975 |
| 03:59 ET | 34555 | 1 |
Apr 26, 2024
Apr 11, 2024
Tevogen Bio's Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers, from 8:05AM ET on Thursday Apr 11, 2024 by Dow Jones
8:05AM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 3, 2024
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development, from 8:05AM ET on Wednesday Apr 03, 2024 by Dow Jones
8:05AM ET on Wednesday Apr 03, 2024 by Dow JonesPress Release: Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development, from 8:05AM ET on Wednesday Apr 03, 2024 by Dow Jones
8:05AM ET on Wednesday Apr 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tevogen Bio Holdings Inc | 154.8M | -2.5x | --- |
Achieve Life Sciences Inc | 157.9M | -3.0x | --- |
Regulus Therapeutics Inc | 158.4M | -1.5x | --- |
Gossamer Bio Inc | 150.7M | -0.5x | --- |
Cytodyn Inc | 142.1M | -2.6x | --- |
Greenwich Lifesciences Inc | 169.0M | -19.0x | --- |
Company Information
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, is an off-the-shelf, allogeneic cytotoxic CD8+ T cell therapy designed to fill a critical gap in COVID-19 therapeutic solutions for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of Long COVID. In addition to TVGN 489, it has several product candidates under early-stage development. The Company is developing Epstein-Barr virus (EBV) specific CTLs for potential use in multiple sclerosis (MS) and EBV-associated lymphomas. Its TVGN 601 is being developed for MS, and its TVGN 930 is being developed for EBV-associated lymphomas.
Contact Information
- Headquarters
- 15 Independence Boulevard, Suite 410WARREN, NJ, United States 07059
- Phone
- 646-807-8832
- Fax
- 302-655-5049
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $154.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 154.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.40 |
Book Value | $-0.22 |
P/E Ratio | -2.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
